Health system consolidation across the nation is changing the clinical and commercial landscape of the healthcare industry. The larger healthcare systems grow, the more patients they must attract and retain.
As the nation progresses through the pandemic and the new normal is established, growing healthcare systems are clinically and commercially sharpening a competitive edge with their digital resources.
These are 5 pivotal areas where hospitals and health systems are optimizing their digital marketing strategies.
To increase access to information and lower costs, healthcare systems are improving the usability of their websites. …
Intellia Therapeutics (NASDAQ: NTLA) and its strategic partner Regeneron are on to something big in gene therapy and anticipation is building for future breakthroughs.
Intellia is a biopharmaceutical research-driven innovator focused on the development of gene-editing therapies to help patients with autoimmune, genetic and oncology healthcare challenges.
It is refining its use of clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing technology and creatively developing new options for patients and medical professionals.
GlaxoSmithKline (GSK) is pulling the trigger on earlier considerations and spinning off its consumer products business unit as a separate company.
It has been reported that GSK (NYSE: GSK) had a divestiture of its consumer products portfolio at least as far back as 2018. They are moving forward with such an exercise that is estimated to generate about $11 billion for their coffers to pay off debt and make strategic investments aligned with their pharmaceutical business.
GSK plans to complete the spinoff by the middle of 2022. Another investor in the consumer products business unit, Pfizer (NYSE…
Merck (NYSE: MRK) spinoff Organon (NYSE: OGN) has completed its acquisition of Alydia Health. Founded in 2010 and based in Menlo Park, California, Alydia is a Women’s Healthcare medical device firm that centers on the prevention of maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding.
Postpartum hemorrhage is one of the most common complications of birth, requiring pharmacologic treatment in up to 10% of mothers and potentially resulting in an emergency intervention such as a hysterectomy and/or blood transfusions. Organon bought Alydia for $240 million.
The FDA has approved Biogen’s (NASDAQ: BIIB) Aduhelm (aducanumab) for the treatment of Alzheimer’s disease, giving patients and medical professionals a desperately needed treatment option of which there are very few. Biogen developed the drug in collaboration with Tokyo, Japan-based Eisai, Co. (OTCMKTS: ESALY).
It has been almost 20 years since the last new Alzheimer’s therapy was approved. There are approximately 6 million persons diagnosed with Alzheimer’s disease in the United States.
HCA Healthcare (NYSE: HCA) and Google (Alphabet-Google NASDAQ: GOOGL) have entered into a deal involving advanced data analytics improving patient care and cost outcomes.
Nashville-based HCA wants to learn more about its patient care performance and how to improve it based on analyzing data from patient records. HCA is one of the largest healthcare provider organizations in the United States.
Founded in 1969, HCA operates 184 hospitals and roughly 2,000 other point-of-care patient service facilities, including various physician practices, surgery centers, and urgent care practices located in 21 states plus the UK.
The sheer scope and size…
Walgreens (NASDAQ: WBA) has shared the encouraging results of an online survey they conducted designed to model the national outlook of those patients receiving a COVID-19 vaccination.
The poll was conducted between April 19 to April 21, 2021, and based on data from:
Walgreens has been administering an array of immunizations at…
Terms of the deal have not been revealed yet but Walmart (NYSE: WMT) has disclosed it is acquiring telehealth innovator MeMD. Founded in 2010, MeMD is a recognized leader in telehealth services nationwide.
Thermo Fisher Scientific (NYSE: TMO) has announced plans to acquire PPD (NASDAQ: PPD) for about $17.4 billion plus the assumption of PPD’s debt which stands around $3.5 billion.
The combination of the two companies pairs two global giants in healthcare diagnostics, medical research and clinical services. Thermo Fisher Scientific is an established leader in diagnostic and medical equipment technology while PPD is one of the largest contract research organizations (CROs) in the world.
Paris-based financial services and insurance giant AXA (OTCMKTS: AXAHY) has selected enterprise technology leader Microsoft (NASDAQ: MSFT) as its partner to build a full-strength telehealth program for its clients and their members.
AXA is one of the largest health insurers in the world. Its plans provide medical coverage to more than 105 consumers and patients in 57 countries. AXA generated about $117.5 billion in sales during 2020.
AXA has no small plans for its telehealth initiative. …
Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/